Skip to content

Auriculotherapy to reduce pain, anxiety and improving the quality of life

Effectiveness of auriculotherapy to reduce pain and anxiety and improving the quality of life of nursing professionals: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5pc43m
Enrollment
Unknown
Registered
2016-04-19
Start date
2015-06-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

musculoskeletal pain, anxiety

Interventions

31 patients will be the control group (no treatment), 35 patients will be submitted to the auricular group with seeds (10 sessions, twice a week), 34 patients will be submitted to the auricular group
Other
E02.190.204

Sponsors

Escola de Enfermagem da Universidade de São Paulo
Lead Sponsor
Leonice Fumiko Sato Kurebayashi
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The subjects of the nursing staff (auxiliaries, technicians and nurses) that present a score above 33 points according to the State-Trait Anxiety Inventory (middle and high level of anxiety) and those who have availability of time for submission to the sessions.

Exclusion criteria

Exclusion criteria: Pregnant women; subjects who go on vacation or sick leave during the research period; those who begin to use allopathic medicines for anxiety and antidepressants during the period of research; those who have metal and adesive tape allergy and who initiate other complementary therapies (acupuncture, massage, herbal medicine, Reiki, Flower therapy etc.) for anxiety control during the period.

Design outcomes

Primary

MeasureTime frame
Reduction of anxiety levels after 5 weeks of treatment. It will be used two instruments to assess anxiety levels (Trait-State Anxiety Inventory and Hamilton Inventory). For finding the expected outcome, a variation of at least 5% will be considered at each scale before and after treatment.

Secondary

MeasureTime frame
Pain after 5 weeks of treatment evaluated from the Analog Visual Scale. For finding the expected outcome, a variation of at least 5% will be considered at the scale before and after treatment.;Quality of Life Improvement of physical and mental aspects after 5 weeks of treatment. It will be used the quality of life instrument (SF12v2).For finding the expected outcome, a variation of at least 5% will be considered at each scale before and after treatment.

Countries

Brazil

Contacts

Public ContactLeonice;Ruth Kurebayashi;Turrini

Escola de Enfermagem da Universidade de São Paulo;Escola de Enfermagem da Universidade de São Paulo

fumieibez@gmail.com;rturrini@usp.br+551155754251;+551199824936

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 27, 2026